A Word From our Experts

Our Thoughts on the Drug Supply Chain, Communicatoin, and DSCSA

Blog DataX

DataX Overview

By Daniel Kraciun | Mar 26, 2024

DataX offers supply chain trading partners enterprise-grade data exchange capabilities, data translation services, intuitive reporting, and cost-effective scaling. Regulatory and technological developments on the pharmaceutical and healthcare supply chain make trading partner data exchange capabilities more important than ever. DataX is a flexible, manageable, and affordable solution.

Read More
Blog EffectiveEPCIS 1

Effective EPCIS Testing

By John Winkler | Mar 22, 2024

The Electronic Product Code Information Services (EPCIS) framework plays a crucial role in enabling seamless and secure information sharing across various stakeholders in the supply chain. To ensure the robustness, reliability, and timely deployment of this system, a comprehensive testing strategy is essential. I’ve outlined our structured approach to testing both the ingestion of EPCIS data from manufacturers or suppliers (inbound) and the dissemination of this information to downstream partners (outbound).

Read More
Blog Registry

Trust.med Registry Launch

By Tom Cooper | Sep 26, 2023

The registry is a catalog of drug product identifiers paired with manufacturer contact information. It’s searchable by National Drug Code (NDC) or Global Trade Item Number (GTIN). We developed it to enhance communication on the drug supply chain.

Read More
Blog WWW 1

Supply Chain Communication

By Lloyd Mager | May 19, 2023

The US drug supply chain regulation envisions a secure Electronic Drug Distribution system that requires authorized trading partners to access and interact with it. So, what exactly is this system and what are your responsibilities within it?

Read More
Blog Aggregation 4

Beyond DSCSA: Aggregation and Exceptions

By Lloyd Mager | Mar 8, 2023

DSCSA does not mandate aggregation. Does that mean you shouldn’t aggregate your data?

Of course not! Since everyone, including manufacturers, will rely on the practice of inference. Aggregation is in fact necessary for interoperable trade in the drug supply chain.

What most manufacturers and distributors don’t yet realize is that aggregated information will become a key component of their exception handling strategy and their ability to demonstrate control.

Read More
Blog DSCSA for Pharmacies 3 Must Knows Data Exchange

DSCSA for Pharmacies: 3 Must Knows

By Daniel Kraciun | Jan 17, 2023

DSCSA for Pharmacies: 3 Must Knows Data Exchange | Partner Verification | Tracing Requests January 17th, 2023 This is the year the pharmaceutical supply chain must comply with the FDA’s Drug Supply Chain Security Act (DSCSA). These requirements must be met in order to operate within the US Drug Supply Chain. As the primary touchpoint … Read more

Read More
Blog Dilemma

The Drug Manufacturer’s DSCSA Dilemma

By Daniel Kraciun | Oct 19, 2022

A decade’s worth of time has expired since the Drug Supply Chain Security Act (DSCSA) was passed to help protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful. This November marks the start of the 12 month countdown requiring pharmaceutical trading partners to comply with the law. As time quickly slips away, trading partners are still left with unanswered questions and serious operational risks if found to be non-compliant by November 27, 2023.

Read More
Blog Resovlers 2

Resolvers: The Internet’s Address Book

By John Winkler | Sep 13, 2022

What exactly does it mean when someone says they have configured a “resolver?” This quick post will explain the concept of a resolver, how Trust.med is using resolvers to address DSCSA compliance, and how you can start using resolvers today…

Read More
Blog AllForOne

All for One, One for All: Interoperable Ecosystems for DSCSA

By Lloyd Mager | Aug 31, 2022

The industry will need the ability to collaborate with each other and connect to relevant distributed data sets within an interoperable ecosystem by November 2023…

Read More